Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas

NCT00005870 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: fluorouracil
DRUG: gemcitabine hydrochloride
DRUG: mitomycin C
DRUG: rubitecan

Sponsor

Astex Pharmaceuticals, Inc.